APA (7th ed.) Citation

DOHERTY, K. (2026). ctDNA Testing Is Poised to Reshape Risk Assessment and Treatment Decision-Making in Bladder Cancer. OncologyLive, 27(5), 18.

Chicago Style (17th ed.) Citation

DOHERTY, KYLE. "CtDNA Testing Is Poised to Reshape Risk Assessment and Treatment Decision-Making in Bladder Cancer." OncologyLive 27, no. 5 (2026): 18.

MLA (9th ed.) Citation

DOHERTY, KYLE. "CtDNA Testing Is Poised to Reshape Risk Assessment and Treatment Decision-Making in Bladder Cancer." OncologyLive, vol. 27, no. 5, 2026, p. 18.

Warning: These citations may not always be 100% accurate.